ESSA Pharma Inc.
EPIX
$0.2456
-$0.0175-6.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.00M | -6.37M | -8.53M | -6.36M | -7.23M |
| Total Depreciation and Amortization | 16.40K | 24.00K | 23.40K | 22.80K | 22.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -615.70K | 993.90K | 2.44M | 2.68M | 2.08M |
| Change in Net Operating Assets | 402.40K | -1.49M | -399.40K | 290.10K | -618.80K |
| Cash from Operations | -4.20M | -6.85M | -6.47M | -3.37M | -5.75M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.84M | -153.90K | -3.93M | 21.02M | 23.50K |
| Cash from Investing | 3.84M | -153.90K | -3.93M | 21.02M | 23.50K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 59.70K | 25.60K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | 59.70K | 25.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | 6.50K | -1.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -355.80K | -7.00M | -10.40M | 17.72M | -5.70M |